BUZZ-Shanghai Fosun Pharmaceutical climbs on vaccine unit's Hong Kong listing plan
Reuters01-23
BUZZ-<a href="https://laohu8.com/S/SFOSF">Shanghai Fosun</a> Pharmaceutical climbs on vaccine unit's Hong Kong listing plan** Shanghai Fosun Pharmaceutical's Hong Kong shares 2196.HK climb 3.1% to HK$20.86, set for biggest one-day pct gain since Jan 13
** Shanghai-listed stock 600196.SS adds 1.7% to 27.72 yuan, biggest one-day pct rise since Jan 5
** Healthcare group's board of directors approves proposed spin-off and listing of vaccine unit Fosun Adgenvax (Chengdu) Biopharmaceutical in Hong Kong
** Spin-off and listing subject to shareholder, China Securities Regulatory Commission, the Stock Exchange and other authorities approvals - co
** YTD, Hong Kong stock up 5.2%, Shanghai-listed shares up 3.9%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
